Ina Frank has joined Alvotech as Vice President, Global Regulatory Affairs based out of our office in Zurich, Switzerland and reporting directly to CEO.
Ina’s background is as tailor-made for Alvotech. Her Regulatory Affairs experience includes five years at various generic companies including Stada and five years at Abbott/Abbvie where she as a Global Regulatory Lead for Humira was responsible for the development of various indications as well as their device. Most recently, Ina spent three years with Boehringer Ingelheim as Team lead for their Biosimilar development activities including the MAA submission for that companies biosimilar adalimumab program.
Ina, is a chemist by training and did her PhD thesis in pharmaceutical chemistry at the Goethe University in Frankfurt before starting her career in Regulatory Affairs.